01.09.2025
Improve Outcomes
$4,007,100.00
36 months
Advancing the development of a novel implantable Glucose Responsive Glucagon (GRG) delivery system
Development of an implantable glucose responsive glucagon delivery system for the prevention of hypoglycemia for people with T1D